– Ideanomics (NASDAQ:IDEX) announced today that Robin Mackie has been appointed Chief Operating Officer and Macy Neshati has been appointed Chief Commercial Officer, effective immediately.
EXCLUSIVE: SAB Biotherapeutics Kickstarts Phase 1 Study For Its Lead Type 1 Diabetes Hopeful In Australia
SAB Biotherapeutics Inc (NASDAQ: SABS) announced that the first HUMAN trial participants (Fully HUman anti-thymocyte biologic in a first-in-MAN clinical study) have been dosed in Australia.